← All trials
NCT04794218
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 23, 2021
- Primary completion
- Jan 1, 2022
- Completion date
- Dec 1, 2022
- First posted
- Mar 11, 2021
- Last posted
- Nov 23, 2021
- Enrollment
- 105
- Arms / groups
- 7 / —
- Source
- AACT · ingestion pipeline
Sponsors
- International AIDS Vaccine InitiativeLead sponsor
- Harvard UniversityCollaborator
- George Washington UniversityCollaborator
- East West Medical Research InstituteCollaborator
- Redemption HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.